215 related articles for article (PubMed ID: 7531356)
1. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
[TBL] [Abstract][Full Text] [Related]
2. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
3. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
4. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat.
Coy DH; Mungan Z; Rossowski WJ; Cheng BL; Lin JT; Mrozinski JE; Jensen RT
Peptides; 1992; 13(4):775-81. PubMed ID: 1279632
[TBL] [Abstract][Full Text] [Related]
5. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
6. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new bombesin receptor antagonist, (E)-alkene bombesin isostere, on amylase release from rat pancreatic acini.
Wada M; Doi R; Hosotani R; Higashide S; Ibuka T; Habashita H; Nakai K; Fujii N; Imamura M
Pancreas; 1995 Apr; 10(3):301-5. PubMed ID: 7542772
[TBL] [Abstract][Full Text] [Related]
8. [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C antagonizes neuromedin C-stimulated amylase release by acini isolated from the rat pancreas.
Wisner JR; Xue BG; Coy DH; Renner IG
Pancreas; 1990 Jul; 5(4):408-14. PubMed ID: 1696379
[TBL] [Abstract][Full Text] [Related]
9. Potent bombesin receptor antagonists distinguish receptor subtypes.
von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
[TBL] [Abstract][Full Text] [Related]
10. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
Amiot F; Leiber D; Marc S; Harbon S
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
[TBL] [Abstract][Full Text] [Related]
11. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
[TBL] [Abstract][Full Text] [Related]
12. Contractile effect of bombesin on guinea pig lung in vitro: involvement of gastrin-releasing peptide-preferring receptors.
Lach E; Haddad EB; Gies JP
Am J Physiol; 1993 Jan; 264(1 Pt 1):L80-6. PubMed ID: 8381599
[TBL] [Abstract][Full Text] [Related]
13. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Groot K; Halmos G
Int J Cancer; 1993 May; 54(2):282-9. PubMed ID: 8387464
[TBL] [Abstract][Full Text] [Related]
14. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.
Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612
[TBL] [Abstract][Full Text] [Related]
15. Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells.
Dickinson KE; Uemura N; Sekar MC; McDaniel HB; Anderson W; Coy DH; Hirschowitz BI
Biochem Biophys Res Commun; 1988 Dec; 157(3):1154-8. PubMed ID: 2462868
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
Wu JM; Hoang DO; Feldman RI
Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
[TBL] [Abstract][Full Text] [Related]
17. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells.
Wang LH; Coy DH; Taylor JE; Jiang NY; Kim SH; Moreau JP; Huang SC; Mantey SA; Frucht H; Jensen RT
Biochemistry; 1990 Jan; 29(3):616-22. PubMed ID: 1692477
[TBL] [Abstract][Full Text] [Related]
18. Role of vagal fibers and bombesin/gastrin-releasing peptide-neurons in distention-induced gastrin release in rats.
Weigert N; Li YY; Schick RR; Coy DH; Classen M; Schusdziarra V
Regul Pept; 1997 Mar; 69(1):33-40. PubMed ID: 9163580
[TBL] [Abstract][Full Text] [Related]
19. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
20. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
Pinski J; Yano T; Groot K; Cai RZ; Radulovic S; Schally AV
Am J Physiol; 1992 Oct; 263(4 Pt 1):E712-7. PubMed ID: 1415689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
